FDA Approves Talzenna for Metastatic, Castration-Resistant Prostate Cancer
MONDAY, June 26, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Talzenna (talazoparib) with enzalutamide for homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).The ap…
Learn MoreLa FDA aprueba nuevos fármacos para tratar la diabetes tipo 2 en niños
MIÉRCOLES, 21 de junio de 2023 (HealthDay News) — El martes, la Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobó dos medicamentos que se han usado en adultos con diabetes tipo 2 durante años para su uso en niños de a partir de 10 añ…
Learn MoreFDA Approves New Drugs to Treat Type 2 Diabetes in Children
WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 years and older.The approvals of Jardiance (empag…
Learn MoreFDA Approves New Drugs to Treat Type 2 Diabetes in Kids
WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin…
Learn MoreFDA Approves Linzess to Treat Constipation in Children, Teens
WEDNESDAY, June 14, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation. The approval was based on data from 328…
Learn MoreFDA Approves Lynparza for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
TUESDAY, June 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Lynparza (olaparib) with abiraterone and prednisone (or prednisolone) for adult patients with deleterious or suspected deleterious BRCA-mutated, metastatic, castr…
Learn MoreFDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia
TUESDAY, May 30, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial …
Learn MoreFDA Grants Full Approval to Paxlovid to Treat COVID-19
THURSDAY, May 25, 2023 (HealthDay News) — Americans with COVID-19 have been taking Paxlovid (nirmatrelvir tablets and ritonavir tablets, copackaged for oral use) since it was approved under emergency use in late 2021. Today, the U.S. Food and Drug Ad…
Learn MoreFDA Approves New Nasal Spray to Reverse Overdoses
TUESDAY, May 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose.To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will be availab…
Learn MoreEpkinly Granted Accelerated FDA Approval for Lymphoma
MONDAY, May 22, 2023 (HealthDay News) — The U.S. Food and Drug Administration has granted accelerated approval to Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from indolent lymph…
Learn More